Anil Kapur
Förmögenhet: 201 184 $ per 2026-06-30
Förmögenhet: 201 184 $ per 2026-06-30
Anil Kapur is currently an Independent Director at Verastem, Inc. since 2022, an independent Director at Nurix Therapeutics, Inc. since 2024, and Head-Legal at Sagar Ratna Restaurants Pvt Ltd. Former positions include Chief Commercial Officer & EVP-Corporate Strategy at Geron Corp.
from 2019 to 2024, Chief Commercial Officer at Actinium Pharmaceuticals, Inc. from 2018 to 2019, Vice President, Head-Early Assets & Biomarkers at Bristol Myers Squibb Co. from 2016 to 2018, VP, Global Head-Commercial & Portfolio Strategy at Baxalta, Inc. from 2015 to 2016, VP & Commercial Leader-Hematology Franchise at Johnson & Johnson from 2013 to 2015, and Legal Advisor at Paras Group.
Education includes undergraduate studies at Birla Institute of Technology & Science and Kurukshetra University, graduate studies at Louisiana Tech University and Kurukshetra University, and an MBA from The Fuqua School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VERASTEM, INC. 0,07 % | 2026-05-21 | 52 666 ( 0,07 % ) | 201 184 $ | 2026-06-30 |
| 2026-05-15 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| VERASTEM, INC. | Direktör/Styrelseledamot | 2022-10-20 |
| NURIX THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-10-15 |
Sagar Ratna Restaurants Pvt Ltd.
Sagar Ratna Restaurants Pvt Ltd. RestaurantsConsumer Services Operates chain of restaurants | Generell Rådgivare | - |
| Företag | Position | Slut |
|---|---|---|
| GERON CORPORATION | Företagsledare/Principal | 2024-08-31 |
| ACTINIUM PHARMACEUTICALS, INC. | Företagsledare/Principal | 2019-11-29 |
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | 2018-02-01 |
| BAXALTA INC | Företagsledare/Principal | 2016-07-01 |
| JOHNSON & JOHNSON | Företagsledare/Principal | 2015-11-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 13 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Birla Institute of Technology & Science
Birla Institute of Technology & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Louisiana Tech University
Louisiana Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kurukshetra University
Kurukshetra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paras Group
Paras Group Other Consumer ServicesConsumer Services Operates as a holding company with interest in personal care, healthcare, real estate, and information technology businesses | Consumer Services |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Sagar Ratna Restaurants Pvt Ltd.
Sagar Ratna Restaurants Pvt Ltd. RestaurantsConsumer Services Operates chain of restaurants | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The Fuqua School of Business
The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån